InvestorsObserver
×
News Home

Is Ibio Inc (IBIO) Stock a Top Performer in the Healthcare Sector?

Tuesday, June 30, 2020 02:39 PM | InvestorsObserver Analysts

Mentioned in this article

Is Ibio Inc (IBIO) Stock a Top Performer in the Healthcare Sector?

Ibio Inc (IBIO) is around the top of the Healthcare sector according to InvestorsObserver.

IBIO received an overall rating of 91, which means that it scores higher than 91% of stocks. Additionally, Ibio Inc scored a 77 in the Healthcare sector, ranking it higher than 77% of stocks in that sector.

Overall Score - 91
IBIO has an Overall Score of 91. Find out what this means to you and get the rest of the rankings on IBIO!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score.

The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Ibio Inc Stock Today?

Ibio Inc (IBIO) stock is lower by -9.15% while the S&P 500 has risen 0.67% as of 2:31 PM on Tuesday, Jun 30. IBIO is down -$0.23 from the previous closing price of $2.46 on volume of 14,646,704 shares. Over the past year the S&P 500 is higher by 3.69% while IBIO has risen 220.00%. IBIO lost -$1.18 per share the over the last 12 months.

To see InvestorsObserver's Sentiment Score for IBIO click here.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App